Argitalpenak (28) Ikertzaileren baten partaidetza izan duten argitalpenak

1999

  1. A high-performance liquid-chromatographic method for the determination of ochratoxin A in human plasma

    Chromatographia, Vol. 50, Núm. 7-8, pp. 457-460

  2. Altered plasma and brain disposition and pharmacodynamics of methadone in abstinent rats

    Journal of Pharmacology and Experimental Therapeutics, Vol. 288, Núm. 1, pp. 179-187

  3. Biotecnología y patentes: ¿reto científico o nuevo negocio?

    Cuadernos de bioética, Vol. 10, Núm. 38, pp. 282-288

  4. Calidad de vida y atención farmacéutica

    El farmacéutico: profesión y cultura, Núm. 232, pp. 74-88

  5. Carbonyl reductase and NADPH cytochrome P450 reductase activities in human tumoral versus normal tissues

    European Journal of Cancer, Vol. 35, Núm. 2, pp. 320-324

  6. Determination of biogenic amines in fermented beverages and vinegars by pre-column derivatization with para-nitrobenzyloxycarbonyl chloride (PNZ-Cl) and reversed-phase LC

    Chromatographia, Vol. 49, Núm. 3-4, pp. 117-124

  7. Economic evaluation of Viaflex® with vial adapter in a unit-dose drug distribution system

    Pharmacy World and Science, Vol. 21, Núm. 6, pp. 278-280

  8. Electrophoretic separation and characterisation of gliadin fractions from isolates and nanoparticulate drug delivery systems

    Chromatographia, Vol. 50, Núm. 3-4, pp. 243-246

  9. Enantiomeric separation of tramadol and its active metabolite in human plasma by chiral high-performance liquid chromatography: Application to pharmacokinetic studies

    Chirality, Vol. 11, Núm. 4, pp. 272-279

  10. Evaluación mutagénica de medicamentos

    Evaluación mutagénica y genotóxica (Dirección General de Enseñanza Superior e Investigación Científica, Ministerio de Educación y Cultura), pp. 263-270

  11. Fexofenadine: a antihistaminic. Review of its practical characteristics

    Revista de medicina de la Universidad de Navarra, Vol. 43, Núm. 2, pp. 93-97

  12. Gliadin nanoparticles: Formation, all-trans-retinoic acid entrapment and release, size optimization

    Polymer International, Vol. 48, Núm. 4, pp. 327-333

  13. Importance of the test medium for the release kinetics of a somatostatin analogue from poly(D,L-lactide-co-glycolide) microspheres

    International Journal of Pharmaceutics, Vol. 184, Núm. 2, pp. 243-250

  14. Influence of colloid stabilizing agents on interactions between nanoparticles and mucus

    S.T.P. Pharma Sciences, Vol. 9, Núm. 5, pp. 437-441

  15. Influence of polyethylene glycol 4000 on the polymorphic forms of diflunisal

    European Journal of Pharmaceutical Sciences, Vol. 8, Núm. 2, pp. 127-132

  16. Methadone: A review of its pharmacokinetic/pharmacodynamic properties

    Journal of Pharmacological and Toxicological Methods, Vol. 42, Núm. 2, pp. 61-66

  17. New quinoxaline 1,4-di-N-oxides for treatment of tuberculosis

    Arzneimittel-Forschung/Drug Research, Vol. 49, Núm. 1, pp. 55-59

  18. Preparation of Ulex europaeus lectin-gliadin nanoparticle conjugates and their interaction with gastrointestinal mucus

    International Journal of Pharmaceutics, Vol. 191, Núm. 1, pp. 25-32

  19. Rapid high-performance liquid chromatographic determination of cefepime in human plasma

    Biomedical Chromatography, Vol. 13, Núm. 4, pp. 272-275

  20. Relationship between pharmacokinetic parameters of gentamicin and patient characteristics and/or clinical data in patients with solid organ turnouts

    Pharmacy World and Science, Vol. 21, Núm. 5, pp. 227-232